Teradata CPO granted 66,007 share units

Arora Sumeet reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Arora Sumeet reported acquisition or exercise transactions in this Form 4 filing.

Teradata chief product officer Sumeet Arora received an equity award of 66,007 shares on March 1, 2026 as a grant, not an open‑market purchase. The award consists of restricted share units that vest in three equal annual installments beginning on March 1, 2027. Following this grant, Arora directly holds 304,097 Teradata common shares, reflecting his ongoing equity-based compensation and alignment with shareholder outcomes.

Insider Trade Summary

Grant/Award: 66,007 shares

Grant/Award 1 txn

Insider Arora Sumeet

Role Chief Product Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	66,007	$0.00	$0.00

Holdings After Transaction: Common Stock — 304,097 shares (Direct)

Footnotes (1)

1. F1. Award of restricted share units which vests in three equal annual installments beginning on March 1, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Teradata (TDC) report for Sumeet Arora?

Teradata reported that chief product officer Sumeet Arora received a grant of 66,007 shares on March 1, 2026. The Form 4 classifies this as an equity award acquisition, not a market purchase or sale, and it increased his directly held Teradata common stock to 304,097 shares.

How many Teradata shares did Sumeet Arora acquire in this Form 4 filing?

Sumeet Arora acquired 66,007 Teradata shares through a grant recorded at a price of $0.00 per share. This award is compensation-related and does not represent an open-market transaction. After the grant, his direct holdings total 304,097 Teradata common shares according to the filing.

Is Sumeet Arora’s Teradata transaction a stock grant or open-market purchase?

The transaction is a stock grant, not an open-market purchase. The Form 4 uses code “A” for a grant, award, or other acquisition, and lists a price of $0.00 per share, indicating compensation-related restricted share units rather than shares bought on the market.

What is the vesting schedule for Sumeet Arora’s 66,007 Teradata restricted share units?

The 66,007 restricted share units vest in three equal annual installments beginning on March 1, 2027. This means one-third of the award becomes transferable each year over three years, providing multi-year incentive alignment tied to Arora’s continued service and performance at Teradata.

What are Sumeet Arora’s Teradata share holdings after this Form 4 transaction?

After this equity award, Sumeet Arora directly holds 304,097 Teradata common shares. This total reflects his position following the 66,007-share grant reported in the Form 4 and highlights the scale of his equity stake as chief product officer of Teradata.

What role does Sumeet Arora hold at Teradata (TDC) in this Form 4 filing?

Sumeet Arora is identified as Teradata’s chief product officer in the Form 4. His position and the size of the 66,007-share grant underscore the company’s use of stock-based compensation to align key executives with long-term shareholder value and product strategy execution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 04:43 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arora Sumeet

(Last) (First) (Middle)

C/O TERADATA CORPORATION

17095 VIA DEL CAMPO

(Street)

SAN DIEGO CA 92127

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TERADATA CORP /DE/ [ TDC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		A(1)		66,007	A	$0	304,097	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of restricted share units which vests in three equal annual installments beginning on March 1, 2027.

Remarks:

	/s/ Juliet C. Shadoan, Attorney-in-fact for Sumeet Arora	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.